| Name: |
|
|
Classification:
|
|
|
Mechanism of Action:
|
- Increases myocardial contractility and ventricular automaticity.
- Stabilizes overly excited myocardial cells in the presence of hyperkalemia. Increased extracellular potassium causes the cellular membrane action potential to decrease which may lead to ECG changes and pre-excitation arrhythmias.
|
|
Indications:
|
- Cardiac arrest patients with suspected hyperkalemia (DKA, renal failure, calcium channel blocker overdose).
- Suspected hyperkalemia with cardiovascular toxicity (wide QRS, peaked T waves and/or sine wave or hemodynamic instability).
- Calcium channel blocker overdose with symptomatic bradycardia or hemodynamic instability.
- Respiratory depression after infusion of magnesium sulfate (decreased diaphragm neuromuscular action).
|
|
Contraindications:
|
- VFib
- Digitalis toxicity
- Hypercalcemia
- Renal or cardiac disease
|
|
Precautions:
|
- Severe local necrosis (infiltration)
- Always flush the line between doses of calcium and bicarbonate to avoid precipitation.
- Ensure the line is patent before calcium administration as to avoid extravasation.
- Consider consulting the Atlantic Canada Poison Centre in the setting of suspected calcium channel blocker overdose.
- Calcium chloride is not the definitive treatment for hyperkalemia. Patients will require treatment with salbutamol, insulin, and possibly renal dialysis at a healthcare facility.
- Routine administration of calcium chloride for cardiac arrest is not recommended.
- Pregnancy category C [if the patient will benefit from a Category C drug, it is generally used]
|
|
Adverse Effects:
|
- Bradycardia
- Hypotension
- Metallic taste
- Cardiac arrest
- Syncope
- Vomiting
|
|
Dose:
|
|
|
Adult:
|
- 1 g over 3 minutes, repeat x 1 in 10 minutes if indications still present.
|
| Pediatric: |
- Cardiac arrest: 20 mg/kg (maximum single dose of 1 g) over 3 minutes, repeat x 1 in 10 minutes if indications still present.
- Non-arrest: 10 mg/kg (maximum single dose of 1 g) over 15 minutes, repeat x 1 in 10 minutes if indications still present.
|
| Routes: |
|
| References: |
- Compendium of Pharmaceuticals and Specialties (CPS)
|
Last modified: Sunday, 16 March 2025, 8:56 PM